Evidence mapPaperPMID 41510180Full record

ArticleKidney diseases (Basel, Switzerland)

Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data.

Juan F Navarro-González, Leopoldo Pérez de Isla, Gloria Cánovas Molina, Miguel Ángel Brito-Sanfiel, David Emilio Barajas Galindo, Luís Ángel Cuellar Olmedo, Dídac Mauricio, Santiago Tofé Povedano, José Antonio Balsa Barro, Matilde Rubio Almanza and 8 more

Abstract read
In one paragraph

Article in Kidney diseases (Basel, Switzerland). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Juan F Navarro-GonzálezUnidad de Investigación y Servicio de Nefrología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Leopoldo Pérez de IslaServicio de Cardiología, Hospital Clínico San Carlos, Madrid, Spain.
Gloria Cánovas MolinaServicio de Endocrinología y Nutrición, Hospital Universitario de Fuenlabrada, Madrid, Spain.
Miguel Ángel Brito-SanfielServicio de Endocrinología y Nutrición, Hospital Universitario Puerta de Hierro, Madrid, Spain.
David Emilio Barajas GalindoServicio de Endocrinología y Nutrición, Hospital Universitario de León, León, Spain.
Luís Ángel Cuellar OlmedoServicio de Endocrinología y Nutrición, Hospital Universitario Río Hortega, Valladolid, Spain.
Dídac MauricioServicio de Endocrinología y Nutrición, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Santiago Tofé PovedanoServicio de Endocrinología y Nutrición, Hospital Universitari Son Espases, Mallorca, Spain.
José Antonio Balsa BarroServicio de Endocrinología y Nutrición, Hospital Universitario Infanta Sofía, Madrid, Spain.
Matilde Rubio AlmanzaServicio de Endocrinología y Nutrición, Departamento de Medicina, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
José Juan Aparicio SánchezDepartamento Médico Cardiovascular, Renal y Metabolismo, AstraZeneca España, Madrid, Spain.
Miren Sequera MutiozabalDepartamento Médico Cardiovascular, Renal y Metabolismo, AstraZeneca España, Madrid, Spain.
Belén PimentelDepartamento Médico Cardiovascular, Renal y Metabolismo, AstraZeneca España, Madrid, Spain.
Ana Pérez DomínguezDepartamento Médico Cardiovascular, Renal y Metabolismo, AstraZeneca España, Madrid, Spain.
Carlos Arias-CabralesSAVANA Research Group, S.A., Madrid, Spain.
Víctor FanjulSAVANA Research Group, S.A., Madrid, Spain.
Antonio Jesús Blanco-CarrascoServicio de Endocrinología y Nutrición, Hospital Clínic de Barcelona, Barcelona, Spain.
Juan Francisco Merino TorresServicio de Endocrinología y Nutrición, Departamento de Medicina, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Persons with type 2 diabetes mellitus (T2DM) attending hospitals frequently experience major complications. We assessed the potential use of unstructured free-text data extracted from electronic health records (EHRs) using natural language processing (NLP) and machine learning (ML) to develop a predictive model for chronic kidney disease (CKD) in T2DM. Methods: This multicenter retrospective study included data from eight Spanish hospitals (2013-2018), extracted using NLP and ML techniques (EHRead®) based on SNOMED CT terminology. From a cohort of individuals with T2DM, we identified those with and without CKD at inclusion. Among individuals without CKD, we trained and validated a 2-year predictive model for CKD development. The model showing the best balance between performance and clinical interpretability was selected for integration into a web-based tool to support early detection and risk stratification. Results: Of 588,786 individuals with T2DM, 316,597 were included for model development (training: 291,429 [92.1%]; validation: 25,168 [7.9%]; CKD incidence: 15.4% and 18.4%, respectively). A high proportion of missing data was observed in key clinical variables. Among models evaluated, logistic regression achieved the best performance (receiver operating characteristic area under the curve 0.72) using 27 predictors. Both a reduced 10-predictor model and a clinically refined 8-predictor model showed comparable performance to the full model in training and validation cohorts. The clinically refined model was selected for implementation in the web-based tool. Conclusion: Unstructured EHR data enabled the development of a predictive model for 2-year CKD risk in persons with T2DM. Improving EHR data completeness remains essential to enhance future predictive modeling.

Indexed as

Chronic kidney diseaseElectronic health recordsMachine learningNatural language processingPredictive modelReal-world dataType 2 diabetes mellitus

Identifiers

PMID41510180
PMCPMC12779294

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.